Top Markets
Coin of the day
Microba Life Sciences Limited Microba Life Sciences Limited

Microba Life Sciences Limited

MAP
Rangering i aksjer #28057
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017,... Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
Aksjekurs
$0.04020123
Markedsverdi
$28.83M
Endring (1 dag)
0.00%
Endring (1 år)
-31.34%
Land
AU
Handel Microba Life Sciences Limited (MAP)

Kategori

Historikk for aksjesplitt for Microba Life Sciences Limited (MAP)
Aksjen Microba Life Sciences Limited (symbol: MAP) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 20, 2026.
Én MAP-aksje kjøpt før Aug 20, 2026 tilsvarer i dag 0 MAP-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US